159 related articles for article (PubMed ID: 15959771)
1. Fast fingerprinting by MALDI-TOF mass spectrometry of urinary sediment glycosphingolipids in Fabry disease.
Touboul D; Roy S; Germain DP; Baillet A; Brion F; Prognon P; Chaminade P; Laprévote O
Anal Bioanal Chem; 2005 Jul; 382(5):1209-16. PubMed ID: 15959771
[TBL] [Abstract][Full Text] [Related]
2. A Novel Rapid MALDI-TOF-MS-Based Method for Measuring Urinary Globotriaosylceramide in Fabry Patients.
Alharbi FJ; Geberhiwot T; Hughes DA; Ward DG
J Am Soc Mass Spectrom; 2016 Apr; 27(4):719-25. PubMed ID: 26797827
[TBL] [Abstract][Full Text] [Related]
3. Global glycosphingolipid analysis in urine and plasma of female Fabry disease patients.
Heywood WE; Doykov I; Spiewak J; Hallqvist J; Mills K; Nowak A
Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2726-2735. PubMed ID: 31319156
[TBL] [Abstract][Full Text] [Related]
4. High-Risk Screening of Fabry Disease: Analysis of Fifteen Urinary Methylated and Non-Methylated Gb
Abaoui M; Boutin M; Lavoie P; Auray-Blais C
Curr Protoc Hum Genet; 2016 Oct; 91():17.24.1-17.24.11. PubMed ID: 27727434
[TBL] [Abstract][Full Text] [Related]
5. Separation and Analysis of Lactosylceramide, Galabiosylceramide, and Globotriaosylceramide by LC-MS/MS in Urine of Fabry Disease Patients.
Boutin M; Menkovic I; Martineau T; Vaillancourt-Lavigueur V; Toupin A; Auray-Blais C
Anal Chem; 2017 Dec; 89(24):13382-13390. PubMed ID: 29099167
[TBL] [Abstract][Full Text] [Related]
6. Analysis of globotriaosylceramide (Gb
Toupin A; Lavoie P; Arthus MF; Abaoui M; Boutin M; Fortier C; Ménard C; Bichet DG; Auray-Blais C
Anal Chim Acta; 2018 Jul; 1015():35-49. PubMed ID: 29530250
[TBL] [Abstract][Full Text] [Related]
7. Tandem mass spectrometry multiplex analysis of methylated and non-methylated urinary Gb3 isoforms in Fabry disease patients.
Abaoui M; Boutin M; Lavoie P; Auray-Blais C
Clin Chim Acta; 2016 Jan; 452():191-8. PubMed ID: 26593248
[TBL] [Abstract][Full Text] [Related]
8. Measurement of urinary CDH and CTH by tandem mass spectrometry in patients hemizygous and heterozygous for Fabry disease.
Mills K; Morris P; Lee P; Vellodi A; Waldek S; Young E; Winchester B
J Inherit Metab Dis; 2005; 28(1):35-48. PubMed ID: 15702404
[TBL] [Abstract][Full Text] [Related]
9. Non-invasive screening method for Fabry disease by measuring globotriaosylceramide in whole urine samples using tandem mass spectrometry.
Kitagawa T; Ishige N; Suzuki K; Owada M; Ohashi T; Kobayashi M; Eto Y; Tanaka A; Mills K; Winchester B; Keutzer J
Mol Genet Metab; 2005 Jul; 85(3):196-202. PubMed ID: 15979031
[TBL] [Abstract][Full Text] [Related]
10. Quantitative evaluation of sphingolipids using delayed extraction matrix-assisted laser desorption ionization time-of-flight mass spectrometry with sphingosylphosphorylcholine as an internal standard. Practical application to cardiac valves from a patient with Fabry disease.
Fujiwaki T; Tasaka M; Takahashi N; Kobayashi H; Murakami Y; Shimada T; Yamaguchi S
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Feb; 832(1):97-102. PubMed ID: 16431168
[TBL] [Abstract][Full Text] [Related]
11. A metabolomic study to identify new globotriaosylceramide-related biomarkers in the plasma of Fabry disease patients.
Manwaring V; Boutin M; Auray-Blais C
Anal Chem; 2013 Oct; 85(19):9039-48. PubMed ID: 23968398
[TBL] [Abstract][Full Text] [Related]
12. High-Risk Screening for Fabry Disease: Analysis by Tandem Mass Spectrometry of Globotriaosylceramide (Gb
Auray-Blais C; Lavoie P; Boutin M; Abaoui M
Curr Protoc Hum Genet; 2017 Apr; 93():17.26.1-17.26.12. PubMed ID: 28384397
[TBL] [Abstract][Full Text] [Related]
13. Optimisation of the separation of four major neutral glycosphingolipids: application to a rapid and simple detection of urinary globotriaosylceramide in Fabry disease.
Roy S; Gaudin K; Germain DP; Baillet A; Prognon P; Chaminade P
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jun; 805(2):331-7. PubMed ID: 15135109
[TBL] [Abstract][Full Text] [Related]
14. Fabry disease urinary globotriaosylceramide/creatinine biomarker evaluation by liquid chromatography-tandem mass spectrometry in healthy infants from birth to 6 months.
Barr C; Clarke JT; Ntwari A; Drouin R; Auray-Blais C
Mol Genet Metab; 2009 Aug; 97(4):278-83. PubMed ID: 19464216
[TBL] [Abstract][Full Text] [Related]
15. Urinary biomarker investigation in children with Fabry disease using tandem mass spectrometry.
Auray-Blais C; Blais CM; Ramaswami U; Boutin M; Germain DP; Dyack S; Bodamer O; Pintos-Morell G; Clarke JT; Bichet DG; Warnock DG; Echevarria L; West ML; Lavoie P
Clin Chim Acta; 2015 Jan; 438():195-204. PubMed ID: 25149322
[TBL] [Abstract][Full Text] [Related]
16. Application of thin-layer chromatography/infrared matrix-assisted laser desorption/ionization orthogonal time-of-flight mass spectrometry to structural analysis of bacteria-binding glycosphingolipids selected by affinity detection.
Müsken A; Souady J; Dreisewerd K; Zhang W; Distler U; Peter-Katalinić J; Miller-Podraza H; Karch H; Müthing J
Rapid Commun Mass Spectrom; 2010 Apr; 24(7):1032-8. PubMed ID: 20213676
[TBL] [Abstract][Full Text] [Related]
17. [Contribution of the measurement of globotriaosylceramide in urine to the diagnosis and follow-up of Fabry disease].
Piraud M; Maire I; Froissart R
Rev Med Interne; 2010 Dec; 31 Suppl 2():S270-4. PubMed ID: 21211678
[TBL] [Abstract][Full Text] [Related]
18. Diurnal Variation of Urinary Fabry Disease Biomarkers during Enzyme Replacement Therapy Cycles.
Boutin M; Lavoie P; Menkovic I; Toupin A; Abaoui M; Elidrissi-Elawad M; Arthus MF; Fortier C; Ménard C; Maranda B; Bichet DG; Auray-Blais C
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32854306
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Globotriaosylceramide (Gb
Boutin M; Maranda B; Waters PJ
Curr Protoc; 2024 Jun; 4(6):e1087. PubMed ID: 38896100
[TBL] [Abstract][Full Text] [Related]
20. Determination of globotriaosylceramide in plasma and urine by mass spectrometry.
Krüger R; Bruns K; Grünhage S; Rossmann H; Reinke J; Beck M; Lackner KJ
Clin Chem Lab Med; 2010 Feb; 48(2):189-98. PubMed ID: 19958207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
